Regulatory Filings • Mar 10, 2025
Regulatory Filings
Open in ViewerOpens in native device viewer
_________ false
| ���� ����� ��"� | 2 379 |
| PURPLE BIOTECH LTD | |
| Corporation no: 520031238 | 12724 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C001 ( Public ) | Reported via MAGNA: | 10/03/2025 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2025-02-015834 | Time of broadcast: 15:35 15:35 |
Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onAttached hereto is Purple Biotech Reports Fourth Quarter and Full-Year 2024 Financial Results
ea023374202-pr_purplebiotechDRAFT3_isa.pdf
Link to filing on foreign stock exchange (optional): _________
| ��� ���� 31.12.24 | |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NASDAQ CM | Date of revision of form structure: 06/08/2024 |
| Address: Oppenheimer, Science Park 4 , Rehovot 7670104 , Israel Tel: 03-9333121 , 03-9311321 Fax: 03-5097196 | |
| E-mail address: [email protected] Company site: www.kitovpharma.com | |
| Previous names of reporting entity: KITOV PHARMA LTD, KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD, | |
| Name of the Signatory: Masas Ludmer Adi Position of Signatory in the reporting corporation: Company Controller Name of Employer Company: | |
| Address: Menachem Begin Drive 132 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: [email protected] 1 | |
| Israel |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.